Creative Medical Technology Holdings, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $14.76M.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $0.00.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $14.76M.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Creative Medical Technology Holdings, Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $2.34M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-12-31 | $14.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $14.76M 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $0.00 10-K · filed 2021-03-17 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $2.34M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | $2.34M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $2.34M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $2.34M 10-K · filed 2020-04-06 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |